Conmed Corp. - Ordinary Shares (NASDAQ: CNMD) stock closed at 134.09 per share at the end of the most recent trading day (a -1.17% change compared to the prior day closing price) with a volume of 187.74K shares and market capitalization of 3.88B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 3400 people. Conmed Corp. - Ordinary Shares CEO is Curt R. Hartman.

The one-year performance of Conmed Corp. - Ordinary Shares stock is 85.63%, while year-to-date (YTD) performance is 19.72%. CNMD stock has a five-year performance of 226.46%. Its 52-week range is between 60.65 and 136.3, which gives CNMD stock a 52-week price range ratio of 97.08%

Conmed Corp. - Ordinary Shares currently has a PE ratio of 435.30, a price-to-book (PB) ratio of 5.33, a price-to-sale (PS) ratio of 5.85, a price to cashflow ratio of 59.60, a PEG ratio of 2.32, a ROA of 0.52%, a ROC of 2.16% and a ROE of 1.28%. The company’s profit margin is 0.47%, its EBITDA margin is 13.70%, and its revenue ttm is $648.45 Million , which makes it $22.40 revenue per share.

Of the last four earnings reports from Conmed Corp. - Ordinary Shares, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.43 for the next earnings report. Conmed Corp. - Ordinary Shares’s next earnings report date is 28th Apr 2021.

The consensus rating of Wall Street analysts for Conmed Corp. - Ordinary Shares is Moderate Buy (2), with a target price of $129.25, which is -3.61% compared to the current price. The earnings rating for Conmed Corp. - Ordinary Shares stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Conmed Corp. - Ordinary Shares has a dividend yield of 0.61% with a dividend per share of $0.80 and a payout ratio of 70.00%.

Conmed Corp. - Ordinary Shares has a Buy technical analysis rating based on Technical Indicators (ADX : 9.29, ATR14 : 4.98, CCI20 : 78.70, Chaikin Money Flow : 0.10, MACD : 1.66, Money Flow Index : 61.29, ROC : -0.08, RSI : 56.77, STOCH (14,3) : 59.10, STOCH RSI : 0.90, UO : 53.62, Williams %R : -40.90), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Conmed Corp. - Ordinary Shares in the last 12-months were: Barbara J Schwarzentraub (Option Excercise at a value of $0), Brian P. Concannon (Option Excercise at a value of $0), Brian P. Concannon (Sold 3 036 shares of value $271 145 ), Charles M. Farkas (Option Excercise at a value of $0), Curt R. Hartman (Sold 0 shares of value $-10 844 640 ), Curt R. Hartman (Sold 35 000 shares of value $3 858 870 ), Daniel S. Jonas (Option Excercise at a value of $1 071 334), Daniel S. Jonas (Sold 21 073 shares of value $2 175 558 ), David M. Bronson (Option Excercise at a value of $0), Heather L. Cohen (Option Excercise at a value of $353 340), Jerome J. Lande (Option Excercise at a value of $0), John E. Kennedy (Option Excercise at a value of $2 260 760), John E. Kennedy (Sold 37 658 shares of value $3 571 271 ), John L. Workman (Option Excercise at a value of $0), Johonna Pelletier (Option Excercise at a value of $1 302 481), Johonna Pelletier (Sold 26 056 shares of value $2 943 928 ), LaVerne Council (Option Excercise at a value of $0), Mark E. Tryniski (Option Excercise at a value of $387 777), Mark E. Tryniski (Sold 8 265 shares of value $1 004 863 ), Martha Goldberg Aronson (Option Excercise at a value of $0), Peter K. Shagory (Sold 0 shares of value $-353 129 ), Peter K. Shagory (Sold 8 640 shares of value $736 173 ), Stanley W. Peters (Sold 0 shares of value $-637 920 ), Stanley W. Peters (Sold 16 500 shares of value $1 636 250 ), Terence M. Berge (Option Excercise at a value of $2 583 877), Terence M. Berge (Sold 66 458 shares of value $7 065 760 ), Todd W. Garner (Option Excercise at a value of $0), Wilfredo Ruiz-Caban (Sold 0 shares of value $-1 686 103 ), Wilfredo Ruiz-Caban (Sold 9 919 shares of value $813 556 )